IFAs should hew to thinking of the market
Excessively discounting plainly visible value within a target company, and making spurious comparisons, may erode confidence in their independence and objectivity
Add BT as a preferred source
[SINGAPORE] This column suggested last week that shareholders of Singapore Paincare think twice about accepting the recently announced offer at S$0.16 per share, and hold out for a better deal.
The privatisation offer by way of scheme of arrangement comes only five years after the company sold shares to investors at S$0.22 each, and listed on the Catalist board of the Singapore Exchange (SGX).
Earlier this week, however, any hope of improved terms were dashed. On Jun 10, the offeror said it did not intend to increase the scheme consideration.
TRENDING NOW
Profit with purpose: Kim Choo Kueh Chang’s pivot from public listing to protecting heritage
Singapore Kitchen CEO, senior manager charged with alleged fraud, falsifying accounts; both to stay in jobs for now
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Should you sacrifice some CPF Life income in favour of ILPs? Tread carefully
